BioMarin, improving lives of rare disease patients

BioMarin is investing €38 million at its plant in Shanbally, Co Cork. It has been seven years since the US pharmaceutical rare disease leader BioMarin first established a presence in Ireland.

Since then, the company has gone from strength to strength. In 2019, it will put its latest expansion plans into action to meet rising demand for its innovative therapies by increasing operational capacity at its Irish manufacturing facility.